Read about CSN in Popular Science magazine!
A patient who suffered years of back pain discusses his leap of faith to participate in stem cell research in Southern California. To read article click here.
DetailsKMIR News interview with Dr. Lander
Healthcare producer Janet Zappala interviews Dr. Lander at his office in Rancho Mirage, California for her “Your Health Matters” news segment. Click here to watch.
Dr. Berman speaks at 1st Annual ARP Seminar
JUNE 5-6 2015 Dr. Berman accepted a position on the Advisory Committee for the Academy of Regenerative Practices (ARP), and presented the following lecture at their first annual conference in Fort Lauderdale, Florida. Mark Berman, MD, FACS presents: “Controlled Studies” A discussion of in-clinic cellular treatments and current empirical findings. Results are largely positive, and dependent upon…
DetailsStem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. The study involved 21 people whose disability due to MS had…
DetailsEvidence-based medicine and intuition both work
Evidence-based medicine and intuition both work By Devorah E. Klein, Gary Klein, and Shawna J. Perry | June 11, 2014, Wednesday | Print Edition EVERY health-care system balances coverage, quality and cost — often focusing on one or two at the expense of the others. It is clear that the US has room for improvement…
DetailsCell Surgical Network performs their first Ophthalmology deployment for Leber’s Optic Neuropathy
Board Certified Ophthalmologist Dr. David Milstein and CSN co-founder Dr. Elliot Lander. Cell Surgical Network performed their first Stromal Vascular Fraction (SVF) retrobulbar deployment for Leber’s optic neuropathy in our Rancho Mirage office. The patient is doing well and we are excited to see the long term benefits of CSN’s new Institutional Review Board (IRB) approved…
DetailsStem Cell Therapy for Thyroid Issues: A New Frontier by Mary Sholom
CSN was pleased to be included in this About.com article by internationally renowned thyroid patient advocate and author Mary Shomon.
BONE MARROW VS. FAT DERIVED STEM CELLS- IS THERE A CONTROVERSY?
BONE MARROW VS. FAT DERIVED STEM CELLS- IS THERE A CONTROVERSY? Whether your adult mesenchymal stem cells come from bone marrow or from fat probably does not make a difference in terms of clinical results. Although some centers claim that bone marrow derived cells are superior to fat derived cells, there is no evidence to…
Details